Funding & investments

Home » Funding & investments

Investment rounds synthetic biology

Why synthetic biology investors need to look beyond Silicon Valley and Boston

Synthetic biology, the field concerned with the design and construction of novel biological systems, has received intense interest from both startup investors and the broader media. The amount of investment in the area...

GreenLight Biosciences Announces $50 Million Funding Round

Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

December 24, 2018 02:00 AM Eastern Standard Time – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases...

News digest #254 – These 98 synthetic biology companies raised $3.8 billion in 2018

These 98 synthetic biology companies raised $3.8 billion in 2018

inscripta

CRISPR is stuck, and this company can fix it

inscripta

In the First Year of Release, Inscripta’s MAD7 CRISPR Enzyme is Widely Adopted by the Gene-Editing Community

Zymergen

Zymergen raises $400M+ to deliver AI-enabled biology to global bio-based industry

Here are 2018’s top articles on SynBioBeta

Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution

Digest #253 – $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!

Mission Bio Raises $30M to Scale the First-ever Platform Aimed at Predicting and Preventing Cancer Relapse with Single-Cell Genomics

Zymergen

Zymergen Announces $400 Million in Series C Funding led by the SoftBank Vision Fund

James Currier

The Ladder of Proof: How VCs see your startup

Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding